Stocks
ANI Pharmaceuticals (ANIP) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 1.44% | 7.91% | 21.9% | 10.3% | 23.5% | 25.5% | ||
| Changes by years, y/y, % | -13pp | +6pp | +14pp | -12pp | +13pp | +11.0% | |||
ANI Pharmaceuticals. EBITDA margin, %
ANI Pharmaceuticals. EBITDA margin, changes, pp
ANI Pharmaceuticals (ANIP) EBITDA margin US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EBITDA margin, % | ? | 7.79% | 24.5% | 18.6% | 26.8% | 31.1% | 25.5% | |
| Changes by years, y/y, % | -9pp | -8pp | +6pp | +36pp | +23pp | |||
| Changes by quarters, q/q, % | +17pp | +17pp | -6pp | +8pp | +4pp | |||
